Rosenberg, Amy S.
EpiVax Incorporated,
United States
2025 Rank: 85019
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1586 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85019 | 88307 |
| Total Cites | 325 | 352 |
| H-index | 9 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 58 | 58 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 119 | 121 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 177 | 180 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 271 | 277 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.27 |
| Self-Citation Percentage |
7.67%
|
|
Rosenberg, Amy S.
Food and Drug Administration,
United States
2022 Rank: 41565
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1054 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41565 | 47655 |
| Total Cites | 436 | 464 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 80 | 80 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 160 | 163 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 263 | 271 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 364 | 377 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.23 |
| Self-Citation Percentage |
6.03%
|
|
Rosenberg, Amy S.
Food and Drug Administration,
United States
2021 Rank: 50248
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1159 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50248 | 53511 |
| Total Cites | 565 | 619 |
| H-index | 12 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 131 | 131 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 224 | 232 |
| Number of Single+First+Last Authored Papers | 58 | 58 |
| Total Cites to Single+First+Last Authored Papers | 312 | 326 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 464 | 488 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.27 |
| Self-Citation Percentage |
8.72%
|
|
Rosenberg, Amy S.
Food and Drug Administration,
United States
2020 Rank: 45689
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Genetics & Heredity
Rank in SubField 1: 994 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45689 | 50275 |
| Total Cites | 435 | 480 |
| H-index | 10 | 10 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 113 | 113 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 175 | 182 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 222 | 239 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 335 | 355 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
9.38%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.